CASE REPORT
SETD5 gene mutation as the cause of short stature
More details
Hide details
1
Department of Medicine, University of Rzeszow, Rzeszów, Poland
2
Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland
3
Department of General and Clinical Genetics, College of Medical Sciences, Institute of Medical Sciences, University of Rzeszów, Rzeszów, Poland
4
Second Department of Pediatrics, Pediatric Endocrinology and Diabetology, Clinical Province Hospital No. 2, Medical College, University of Rzeszów, Poland
Submission date: 2023-04-11
Final revision date: 2023-07-31
Acceptance date: 2023-09-12
Publication date: 2024-03-02
Pediatr Pol 2024;99(1):94-98
KEYWORDS
TOPICS
ABSTRACT
An 8-year-old boy was referred to the Clinic of Pediatric Endocrinology due to his short stature. The child comes from P II B II, was born naturally, with birth weight 2970 g. He had dysmorphism and a height of 118 cm (3rd centile). Growth hormone (GH) deficiency and other causes of short stature were excluded. A genetic panel was performed using next generation sequencing, which revealed a pathogenic variant in the SETD5 gene, with which growth deficiency is not typically associated. Literature reports suggest that genetically determined conditions with transcriptional effects, GH deficiency, and intellectual disability may overlap phenotypically. The most likely cause of short stature in this case is a genetic mutation in the SETD5 gene. The boy requires multidisciplinary care, including auxological assessment, growth monitoring, puberty assessment, and pediatric and endocrinological care. All children with short stature and dysmorphic features or body proportion abnormalities who receive GH therapy require genetic testing.
REFERENCES (11)
1.
Pietrzyk JJ. Wybrane zagadnienia z pediatrii, tom IV. Wydawnictwo Uniwersytetu Jagiellońskiego, Kraków 2005, 15-16.
2.
Korpysz A, Wysocka-Mincewicz M, Szalecki M. Evaluation of selected parameters change carbohydrate in children born with IUGR age prepubertal and adolescent comparing to AGA. Endokrynol Ped 2017; 16: 171-176.
3.
Barstow C, Rerucha C. Evaluation of short and tall stature in children. Am Family Physician 2015; 92: 43-50.
4.
Fang YL, Zhang RP, Wang YZ, et al. A novel mutation in a common pathogenic gene (SETD5) associated with intellectual disability: a case report. Exp Ther Med 2019; 18: 3737-3740.
5.
Fernandes IR, Cruz A, Ferrasa A, Phan D, Herai RH, Muotri AR. Genetic variations on SETD5 underlying autistic conditions. Dev Neurobiol 2018; 78: 500-518.
6.
Parenti I, Pozojevic J, Bader I, et al. Mutations in chromatin regulators functionally link Cornelia de Lange syndrome and clinically overlapping phenotypes. Human Genetics 2017; 136: 307-320.
7.
Cheetham T, Davies JH. Investigation and management of short stature. Arch Dis Child 2014; 99: 767-771.
8.
Green C, Willoughby J. De novo SETD5 loss-of-function variant as a cause for intellectual disability in a 10-year old boy with an aberrant blind ending bronchus. Am J Med Genet A 2017; 173: 3165-3171.
9.
Crippal M, Bestetti I, Maitz S, et al. SETD5 gene haploinsufficiency in three patients with suspected KBG syndrome. Front Neurol 2020; 11: 631.
10.
Kuechler A, Zink AM, Wieland T, et al. Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome. Eur J Hum Genet 2015; 23: 753-760.
11.
Hokken-Koelega A, van der Steen M, Boguszewski M, et al. International Consensus Guideline on Small for Gestational Age: etiology and management from infancy to early adulthood. Endocr Rev 2023; 44: 1-27.